tiprankstipranks
Bicycle Therapeutics (BCYC)
NASDAQ:BCYC
US Market
BCYC
Bicycle Therapeutics
RESEARCH TOOLSreports

Bicycle Therapeutics (BCYC) Financial Statements

Compare
408 Followers

Bicycle Therapeutics Financial Overview

Bicycle Therapeutics's market cap is currently $312.16M. The company's EPS TTM is $-0.29; its P/E ratio is ―; Bicycle Therapeutics is scheduled to report earnings on March 17, 2026, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 72.59M$ 35.27M$ 26.98M$ 14.46M$ 11.70M
Gross Profit$ 72.59M$ -137.69M$ -129.52M$ 14.46M$ 11.70M
Operating Income$ -247.06M$ -209.87M$ -189.95M$ -116.65M$ -65.62M
EBITDA$ -276.86M$ -164.89M$ -183.40M$ -107.21M$ -64.09M
Net Income$ -218.96M$ -169.03M$ -180.66M$ -112.72M$ -66.82M
Balance Sheet
Cash & Short-Term Investments$ 628.11M$ 879.52M$ 526.42M$ 339.15M$ 438.68M
Total Assets$ 717.60M$ 956.87M$ 595.34M$ 410.61M$ 479.79M
Total Debt$ 17.52M$ 9.49M$ 44.96M$ 44.33M$ 44.34M
Net Debt$ -610.59M$ -870.03M$ -481.47M$ -294.83M$ -394.34M
Total Liabilities$ 107.62M$ 163.81M$ 224.41M$ 139.83M$ 133.54M
Stockholders' Equity$ 609.98M$ 793.06M$ 370.93M$ 270.78M$ 346.25M
Cash Flow
Free Cash Flow$ -252.61M$ -165.96M$ -63.56M$ -105.10M$ -16.82M
Operating Cash Flow$ -249.68M$ -164.72M$ -60.63M$ -86.11M$ -14.79M
Investing Cash Flow$ -2.35M$ -1.24M$ -2.93M$ -18.99M$ -2.03M
Financing Cash Flow$ -131.00K$ 519.75M$ 250.03M$ 6.69M$ 320.73M
Currency in USD

Bicycle Therapeutics Earnings and Revenue History

Income Statement >

Bicycle Therapeutics Debt to Assets

Balance Sheet >

Bicycle Therapeutics Cash Flow

Cash Flow >

Bicycle Therapeutics Forecast EPS vs Actual EPS

Earnings >